Alexandria Pharmaceuticals and Chemical Industries posted financial indicators for the first quarter of the fiscal year 2014/2015.
These indicators showed EGP 13.31 million net profit after tax, representing an increase by 8.4% compared with EGP 12.278 million net profit in the same period a year earlier.
The company had posted EGP 47.8 million net profit for the fiscal year 2013/2014, a decline by 0.3% from EGP 47.9 million a year earlier.
The company’s financial results for the 11-month period from July 1, 2013 till May 31, 2014 had shown net profit of EGP 45.4 million, with a slight rise by 0.02% compared with EGP 45.3 million in the same period a year earlier.